Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study

Liang, 2009, Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination, Vaccine, 27, 6550, 10.1016/j.vaccine.2009.08.048 Schutte, 2013, Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany, Digestion, 87, 147, 10.1159/000346743 Nayak, 2010, End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program, Hum Pathol, 41, 425, 10.1016/j.humpath.2009.06.021 Michitaka, 2010, Etiology of liver cirrhosis in Japan: a nationwide survey, J Gastroenterol, 45, 86, 10.1007/s00535-009-0128-5 Schuppan, 2008, Liver cirrhosis, Lancet, 371, 838, 10.1016/S0140-6736(08)60383-9 Fleming, 2008, Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: A general population-based study, J Hepatol, 49, 732, 10.1016/j.jhep.2008.05.023 Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J Hepatol, 45, 529, 10.1016/j.jhep.2006.05.013 Huang, 2015, Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012, Epidemiol Infect, Jan 20, 1 Qing, 2007, Seroepidemiological Survey and Analysis of Virus Hepatitis C in Chongqing, J Prev Med Inf, 23, 152 Tanaka, 2011, Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures, Journal of Epidemiology, 21, 401, 10.2188/jea.JE20100190 Yim, 2006, Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005, Hepatology, 43, S173, 10.1002/hep.20956 Liang, 2009, Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China, J Infect Dis, 200, 39, 10.1086/599332 Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183 Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x Fan, 2013, Epidemiology of alcoholic and nonalcoholic fatty liver disease in China, J Gastroenterol Hepatol, 28, 11, 10.1111/jgh.12036 Fan, 2009, Epidemiology of non-alcoholic fatty liver disease in China, J Hepatol, 50, 204, 10.1016/j.jhep.2008.10.010 Caldwell, 2004, Obesity and hepatocellular carcinoma, Gastroenterology, 127, S97, 10.1053/j.gastro.2004.09.021 Karagozian, 2014, Obesity-associated mechanisms of hepatocarcinogenesis, Metabolism, 10.1016/j.metabol.2014.01.011 Mena, 2014, Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers, J Gastroenterol Hepatol, 29, 173, 10.1111/jgh.12432 Kristi, 2007, Prevalence and risk factors of overweight and obesity in China, Brief Epidemiologic Report, 15, 10 CM, 2008, Overview of obesity in Mainland China, Obesity reviews, 9, 14 Dongdong Liu, 2013, Survey on obesity of 24343 children under 7 years old in Tianjing, Zhong Guo Fu You Bao Jian, 28, 3646 Corey, 2014, Obesity and liver disease: the epidemic of the twenty-first century, Clin Liver Dis, 18, 1, 10.1016/j.cld.2013.09.019 Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527 Jing Gao, 2012, Incidence and mortality of primary liver cancer in Shanghai, 2006-2008, Tumor, 32, 526 Chen, 2013, Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan, Kaohsiung J Med Sci, 29, 451, 10.1016/j.kjms.2012.12.006 Kawada, 2009, Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis, J Gastroenterol, 44, 1190, 10.1007/s00535-009-0112-0 Yasui, 2012, Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma, Hepatol Res, 42, 767, 10.1111/j.1872-034X.2012.00986.x Berentzen, 2014, Body mass index in childhood and adult risk of primary liver cancer, J Hepatol, 60, 325, 10.1016/j.jhep.2013.09.015 Jessica Dyson, 2014, Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team, Journal of hepatology, 60, 110, 10.1016/j.jhep.2013.08.011 Rodrigues, 2014, Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women, Gynecol Endocrinol, 30, 325, 10.3109/09513590.2013.875992 Hamaguchi, 2012, Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women, World J Gastroenterol, 18, 237, 10.3748/wjg.v18.i3.237 Shimizu, 2007, Protection of estrogens against the progression of chronic liver disease, Hepatol Res, 37, 239, 10.1111/j.1872-034X.2007.00032.x